chr16-16198114-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001171.6(ABCC6):c.1245G>A(p.Val415Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.323 in 1,611,634 control chromosomes in the GnomAD database, including 87,433 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.30 ( 7118 hom., cov: 33)
Exomes 𝑓: 0.33 ( 80315 hom. )
Consequence
ABCC6
NM_001171.6 synonymous
NM_001171.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.804
Publications
18 publications found
Genes affected
ABCC6 (HGNC:57): (ATP binding cassette subfamily C member 6) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008]
ABCC6 Gene-Disease associations (from GenCC):
- arterial calcification, generalized, of infancy, 2Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- autosomal recessive inherited pseudoxanthoma elasticumInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), G2P
- arterial calcification of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 16-16198114-C-T is Benign according to our data. Variant chr16-16198114-C-T is described in ClinVar as Benign. ClinVar VariationId is 433228.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.804 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.343 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ABCC6 | NM_001171.6 | c.1245G>A | p.Val415Val | synonymous_variant | Exon 10 of 31 | ENST00000205557.12 | NP_001162.5 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ABCC6 | ENST00000205557.12 | c.1245G>A | p.Val415Val | synonymous_variant | Exon 10 of 31 | 1 | NM_001171.6 | ENSP00000205557.7 | ||
| ABCC6 | ENST00000574094.6 | c.1245G>A | p.Val415Val | synonymous_variant | Exon 10 of 11 | 5 | ENSP00000507301.1 | |||
| ABCC6 | ENST00000456970.6 | n.1245G>A | non_coding_transcript_exon_variant | Exon 10 of 29 | 2 | ENSP00000405002.2 | ||||
| ABCC6 | ENST00000622290.5 | n.1245G>A | non_coding_transcript_exon_variant | Exon 10 of 32 | 5 | ENSP00000483331.2 |
Frequencies
GnomAD3 genomes AF: 0.297 AC: 45196AN: 152046Hom.: 7122 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
45196
AN:
152046
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.285 AC: 70039AN: 245644 AF XY: 0.286 show subpopulations
GnomAD2 exomes
AF:
AC:
70039
AN:
245644
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.326 AC: 475529AN: 1459470Hom.: 80315 Cov.: 51 AF XY: 0.323 AC XY: 234251AN XY: 725842 show subpopulations
GnomAD4 exome
AF:
AC:
475529
AN:
1459470
Hom.:
Cov.:
51
AF XY:
AC XY:
234251
AN XY:
725842
show subpopulations
African (AFR)
AF:
AC:
8332
AN:
33462
American (AMR)
AF:
AC:
11945
AN:
44404
Ashkenazi Jewish (ASJ)
AF:
AC:
5803
AN:
26070
East Asian (EAS)
AF:
AC:
3580
AN:
39646
South Asian (SAS)
AF:
AC:
18836
AN:
85850
European-Finnish (FIN)
AF:
AC:
16681
AN:
53208
Middle Eastern (MID)
AF:
AC:
1691
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
390803
AN:
1110788
Other (OTH)
AF:
AC:
17858
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
18246
36491
54737
72982
91228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
12258
24516
36774
49032
61290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.297 AC: 45189AN: 152164Hom.: 7118 Cov.: 33 AF XY: 0.291 AC XY: 21661AN XY: 74398 show subpopulations
GnomAD4 genome
AF:
AC:
45189
AN:
152164
Hom.:
Cov.:
33
AF XY:
AC XY:
21661
AN XY:
74398
show subpopulations
African (AFR)
AF:
AC:
10507
AN:
41522
American (AMR)
AF:
AC:
4502
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
775
AN:
3472
East Asian (EAS)
AF:
AC:
495
AN:
5160
South Asian (SAS)
AF:
AC:
997
AN:
4822
European-Finnish (FIN)
AF:
AC:
3283
AN:
10600
Middle Eastern (MID)
AF:
AC:
76
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23578
AN:
67976
Other (OTH)
AF:
AC:
638
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1655
3311
4966
6622
8277
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
513
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive inherited pseudoxanthoma elasticum Benign:2
Mar 01, 2021
PXE International
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:research
- -
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arterial calcification, generalized, of infancy, 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Pseudoxanthoma elasticum, forme fruste Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive inherited pseudoxanthoma elasticum;C1867450:Pseudoxanthoma elasticum, forme fruste;C3276161:Arterial calcification, generalized, of infancy, 2 Benign:1
Aug 27, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.